HK1026151A1 - Stabilized protein compositions - Google Patents

Stabilized protein compositions

Info

Publication number
HK1026151A1
HK1026151A1 HK00105539A HK00105539A HK1026151A1 HK 1026151 A1 HK1026151 A1 HK 1026151A1 HK 00105539 A HK00105539 A HK 00105539A HK 00105539 A HK00105539 A HK 00105539A HK 1026151 A1 HK1026151 A1 HK 1026151A1
Authority
HK
Hong Kong
Prior art keywords
protein compositions
stabilized protein
stabilized
compositions
protein
Prior art date
Application number
HK00105539A
Other languages
English (en)
Inventor
Peter Connor Canning
Barbara Jean Kamicker
Kasra Kasraian
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1026151A1 publication Critical patent/HK1026151A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00105539A 1998-08-17 2000-09-04 Stabilized protein compositions HK1026151A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9687698P 1998-08-17 1998-08-17

Publications (1)

Publication Number Publication Date
HK1026151A1 true HK1026151A1 (en) 2000-12-08

Family

ID=22259521

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105539A HK1026151A1 (en) 1998-08-17 2000-09-04 Stabilized protein compositions

Country Status (17)

Country Link
US (1) US20050232898A1 (ja)
EP (1) EP0988861B1 (ja)
JP (1) JP3641170B2 (ja)
CN (1) CN1250282C (ja)
AR (1) AR016504A1 (ja)
AT (1) ATE260674T1 (ja)
AU (2) AU767431B2 (ja)
BR (1) BR9904150A (ja)
CA (1) CA2280449A1 (ja)
DE (1) DE69915204T2 (ja)
DK (1) DK0988861T3 (ja)
ES (1) ES2216447T3 (ja)
HK (1) HK1026151A1 (ja)
NZ (2) NZ510140A (ja)
PT (1) PT988861E (ja)
TW (1) TWI221773B (ja)
ZA (1) ZA995201B (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60103940T2 (de) * 2000-02-29 2005-07-28 Pfizer Products Inc., Groton Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
EP1391209A4 (en) * 2001-05-30 2009-12-16 Chugai Pharmaceutical Co Ltd PROTEIN PREPARATION
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
ITBA20020032A1 (it) * 2002-09-24 2004-03-25 Bio D Soc Metodo per stabilizzare le proteine per la conservazione ad alte temperature.
JP2006526016A (ja) * 2003-05-09 2006-11-16 シエーリング アクチエンゲゼルシャフト 炎症性呼吸器疾患の治療
SI1682184T1 (sl) 2003-11-04 2014-02-28 Lek Pharmaceuticals D.D. Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov
EP1537876A1 (en) * 2003-12-01 2005-06-08 BioGeneriX AG Erythropoietin solution formulation
US20050124702A1 (en) * 2003-12-09 2005-06-09 Alcon, Inc. Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
ES2458991T3 (es) * 2004-11-12 2014-05-07 Novo Nordisk A/S Formulaciones estables de péptidos insulinotrópicos
PT1787658E (pt) * 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento
DE102006009437A1 (de) * 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
US7705132B2 (en) 2006-10-20 2010-04-27 Amgen Inc. Stable polypeptide formulations
ES2524454T3 (es) 2007-08-27 2014-12-09 Ratiopharm Gmbh Formulación líquida de G-CSF
EP2197970B1 (en) * 2007-10-09 2011-07-20 Hercules Incorporated Crosslinkercontaining adhesive compositions
JP5680534B2 (ja) * 2008-07-23 2015-03-04 イーライ リリー アンド カンパニー 修飾されているウシｇ−ｃｓｆポリペプチドおよびそれらの使用
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
GB2516808A (en) 2013-05-31 2015-02-11 Innova Biosciences Ltd Antibody composition and buffer system therefor
US11464831B2 (en) 2015-01-05 2022-10-11 Cornell University Compositions and methods using IL-8 for improving health of mammals
EP3242675B1 (en) 2015-01-05 2022-11-30 Cornell University Compositions and methods using il-8 to improve milk production and reproductive health in mammals
ES2952744T3 (es) 2016-12-15 2023-11-03 Nestle Sa Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía
EP3771463A1 (en) 2019-07-29 2021-02-03 Ludwig-Maximilians-Universität München Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
CN116836920B (zh) * 2023-08-21 2024-05-24 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 一种无血清培养基及其制备间充质干细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
WO1989010932A1 (en) * 1988-05-13 1989-11-16 Amgen Inc. Compositions and method for treating or preventing infections in animals
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof

Also Published As

Publication number Publication date
AR016504A1 (es) 2001-07-04
AU767431B2 (en) 2003-11-13
JP2000063264A (ja) 2000-02-29
CN1250668A (zh) 2000-04-19
TWI221773B (en) 2004-10-11
PT988861E (pt) 2004-06-30
NZ510140A (en) 2005-01-28
DE69915204T2 (de) 2004-07-29
CA2280449A1 (en) 2000-02-17
ATE260674T1 (de) 2004-03-15
ZA995201B (en) 2001-02-16
EP0988861B1 (en) 2004-03-03
CN1250282C (zh) 2006-04-12
AU4450199A (en) 2000-03-09
EP0988861A1 (en) 2000-03-29
NZ337258A (en) 2001-04-27
US20050232898A1 (en) 2005-10-20
JP3641170B2 (ja) 2005-04-20
ES2216447T3 (es) 2004-10-16
AU2004200568A1 (en) 2004-03-11
BR9904150A (pt) 2000-12-26
DE69915204D1 (de) 2004-04-08
DK0988861T3 (da) 2004-04-19

Similar Documents

Publication Publication Date Title
EP1113799A4 (en) PROTEIN-BASED PREPARATION
AP2000001874A0 (en) Cellecoxib compositions
GB9917982D0 (en) Compositions
GB9811377D0 (en) Compositions
HK1026151A1 (en) Stabilized protein compositions
GB9924268D0 (en) Compositions
GB9828861D0 (en) Compositions
PL344979A1 (en) Angiostatin-binding protein
GB2339693B (en) Anti-mollusc compositions
GB9905325D0 (en) Compositions
GB9905746D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9827291D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB2336535B (en) Compositions
GB9828880D0 (en) Protein
GB9809347D0 (en) Compositions
GB9827690D0 (en) Compositions
GB9816050D0 (en) Compositions
GB9812607D0 (en) Protein
GB9809566D0 (en) Protein
GB9819038D0 (en) Protein
GB9818278D0 (en) Compositions
GB9816096D0 (en) Protein
GB9823975D0 (en) Protein

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100817